The results of our study suggest that TM7SF2/C-Raf/ERK1/2 axis exerts an essential effect on the progression of cervical cancer and targeting TM7SF2 may be a promising method to treat cervical cancer. The gene discussed is RAF1; the disease is cervical carcinoma.